Reuters logo
BRIEF-Zhejiang Jingxin Pharma to take a stake in U.S. firm Spes Pharmaceuticals Inc
June 26, 2017 / 9:00 AM / 3 months ago

BRIEF-Zhejiang Jingxin Pharma to take a stake in U.S. firm Spes Pharmaceuticals Inc

June 26 (Reuters) - Zhejiang Jingxin Pharmaceutical Co Ltd

* Says it plans to invest up to $2.0 million in U.S. Spes Pharmaceuticals Inc for no more than 25 percent stake

Source text in Chinese: bit.ly/2u6sGuQ

Further company coverage: (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below